Mirza Wajahat, Moaz Muhammad, Turab Muhammad Sajeel, Khan Hadi Mohammad, Dadan Sundus, Yasmin Saeeda, Tareen Abdullah Khan, Hanif Hamza
Shifa College of Medicine, Shifa Tameer-e-Millat University, Sector H-8/4, Islamabad, Pakistan.
Department of General Surgery and Surgical Oncology, Shifa International Hospital, Islamabad, Pakistan.
World J Surg Oncol. 2025 Aug 27;23(1):322. doi: 10.1186/s12957-025-03959-z.
Achieving optimal surgical margins is critical in breast-conserving surgery (BCS) to reduce local recurrence (LR) and the need for re-excision. This meta-analysis evaluated the impact of intraoperative margin optimization strategies on key surgical and oncologic outcomes in patients who underwent BCS.
A systematic review and meta-analysis were conducted according to the PRISMA guidelines, including six randomized controlled trials (RCTs). The outcomes assessed included the re-excision rate (primary outcome), positive margin rate, local recurrence (LR), and overall survival (OS). The risk of bias was evaluated using the ROB 2 tool, and the certainty of evidence was assessed using GRADE. The study protocol was prospectively registered in the PROSPERO database ( CRD420251000564 ).
Intraoperative margin optimization significantly reduced re-excision rates (OR 0.54, 95% CI 0.32-0.90), corresponding to 169 fewer re-excisions per 1,000 patients. Positive margin rates were also significantly lower (OR 0.40, 95% CI 0.22-0.73), translating to 139 fewer positive margins per 1,000 patients. No statistically significant differences were observed for LR (OR 0.72, 95% CI, 0.16-3.19) or OS (OR 0.87, 95% CI, 0.73-1.03).
Intraoperative margin optimization effectively reduces positive margins and re-excisions in BCS without adversely affecting LR or OS. The incorporation of these strategies should be considered a standard practice to enhance surgical quality and patient outcomes.
在保乳手术(BCS)中,实现最佳手术切缘对于降低局部复发(LR)和再次切除的必要性至关重要。本荟萃分析评估了术中切缘优化策略对接受BCS患者的关键手术和肿瘤学结局的影响。
根据PRISMA指南进行了系统评价和荟萃分析,包括六项随机对照试验(RCT)。评估的结局包括再次切除率(主要结局)、切缘阳性率、局部复发(LR)和总生存期(OS)。使用ROB 2工具评估偏倚风险,并使用GRADE评估证据的确定性。该研究方案已在PROSPERO数据库(CRD420251000564)中进行前瞻性注册。
术中切缘优化显著降低了再次切除率(OR 0.54,95%CI 0.32-0.90),相当于每1000例患者中再次切除减少169例。切缘阳性率也显著降低(OR 0.40,95%CI 0.22-0.73),即每1000例患者中切缘阳性减少139例。在LR(OR 0.72,95%CI 0.16-3.19)或OS(OR 0.87,95%CI 0.73-1.03)方面未观察到统计学显著差异。
术中切缘优化可有效降低BCS中的切缘阳性和再次切除率,且不会对LR或OS产生不利影响。应考虑将这些策略纳入标准实践,以提高手术质量和患者结局。